Apomorphine

Active ingredient description

Apomorphine is a direct stimulant of dopamine receptors and while possessing both D1 and D2 receptor agonist properties does not share transport or metabolic pathways with levodopa. Its actions on parkinsonian motor disability are likely to be mediated at post-synaptic receptor sites.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
G04BE07
Apomorphine
G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE07
N04BC07
Apomorphine
N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC07

Medicines

Apomorphine is the active ingredient of these drugs:

Drug
Countries
APO-GO

Austria Cyprus Finland Ireland Netherlands

APOKINON

France Tunisia

APOKYN

United States

APOMINE

Australia

BRITAJECT

Lithuania

DACEPTON

Austria Finland Ireland Lithuania Netherlands

DOPACEPTIN

France

KYNMOBI

Canada United States

MOVAPO

Australia Canada New Zealand

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
KYNMOBI Sublingual film
Structured Product Labeling (SPL/PLR)
US
APO-GO Solution for injection
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

N21FAR7B4S - APOMORPHINE

CAS registry number

41372-20-7 - Apomorphine

SNOMED-CT

387375001 - Apomorphine (substance)

Next: Usage